Literature DB >> 21679263

Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence.

Jennifer D J Hobbs1, Matt G Kushner, Susanne S Lee, Sean M Reardon, Eric W Maurer.   

Abstract

Approximately half of those receiving treatment for an alcohol use disorder (AUD) also suffer with an anxiety or depressive (internalizing) disorder. Because all internalizing disorders mark a poor alcohol treatment outcome, it seems reasonable to supplement AUD treatment with a psychiatric intervention when these disorders co-occur with AUD. However, this conclusion may be faulty given that the various possible interrelationships between AUD and internalizing disorders do not uniformly imply a high therapeutic yield from this approach. Unfortunately, the studies conducted to date have been too few and too small to resolve this important clinical issue with confidence. Therefore, we used a meta-analytic method to synthesize the effects from published randomized controlled trials examining the impact of supplementing AUD treatment with a psychiatric treatment for co-occurring internalizing disorder (N = 15). We found a pooled effect size (d) of .32 for internalizing outcomes and .22 for a composite of alcohol outcomes; however, the alcohol outcomes effect sizes were greater than this for some specific outcome domains. Subgroups that differed in terms of internalizing outcomes included treatment type (medication vs. cognitive behavioral therapy) and treatment focus (anxiety vs. depression). There was also a trend for the studies with better internalizing disorder outcomes to have better alcohol outcomes. These results indicate that clinical outcomes (both psychiatric and alcohol-related) could be somewhat improved by supplementing AUD treatment with psychiatric treatment for co-occurring internalizing disorder. © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21679263      PMCID: PMC3124006          DOI: 10.1111/j.1521-0391.2011.00140.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  63 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Paroxetine for social anxiety and alcohol use in dual-diagnosed patients.

Authors:  C L Randall; M R Johnson; A K Thevos; S C Sonne; S E Thomas; S L Willard; K T Brady; J R Davidson
Journal:  Depress Anxiety       Date:  2001       Impact factor: 6.505

3.  Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.

Authors:  P P Roy-Byrne; K P Pages; J E Russo; C Jaffe; A W Blume; E Kingsley; D S Cowley; R K Ries
Journal:  J Clin Psychopharmacol       Date:  2000-04       Impact factor: 3.153

Review 4.  Placebo response in studies of major depression: variable, substantial, and growing.

Authors:  B Timothy Walsh; Stuart N Seidman; Robyn Sysko; Madelyn Gould
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

5.  Do comorbid anxiety disorders in alcohol-dependent patients need specific treatment to prevent relapse?

Authors:  Annemiek Schadé; Loes A Marquenie; Anton J L M Van Balkom; Edwin De Beurs; Richard Van Dyck; Wim Van Den Brink
Journal:  Alcohol Alcohol       Date:  2003 May-Jun       Impact factor: 2.826

6.  The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women.

Authors:  Kenneth S Kendler; Carol A Prescott; John Myers; Michael C Neale
Journal:  Arch Gen Psychiatry       Date:  2003-09

7.  Are placebo controls necessary to test new antidepressants and anxiolytics?

Authors:  Arif Khan; Shirin Khan; Walter A Brown
Journal:  Int J Neuropsychopharmacol       Date:  2002-09       Impact factor: 5.176

8.  Sertraline for the prevention of relapse in detoxicated alcohol dependent patients with a comorbid depressive disorder: a randomized controlled trial.

Authors:  A Gual; M Balcells; M Torres; M Madrigal; T Diez; L Serrano
Journal:  Alcohol Alcohol       Date:  2003 Nov-Dec       Impact factor: 2.826

9.  Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial.

Authors:  Darlene H Moak; Raymond F Anton; Patricia K Latham; Konstantin E Voronin; Randolph L Waid; Ramon Durazo-Arvizu
Journal:  J Clin Psychopharmacol       Date:  2003-12       Impact factor: 3.153

10.  Pharmacological treatment of social anxiety disorder: a meta-analysis.

Authors:  Carlos Blanco; Franklin R Schneier; Andrew Schmidt; Carmen-Rosa Blanco-Jerez; Randall D Marshall; Arturo Sánchez-Lacay; Michael R Liebowitz
Journal:  Depress Anxiety       Date:  2003       Impact factor: 6.505

View more
  28 in total

1.  Religiosity profiles of American youth in relation to substance use, violence, and delinquency.

Authors:  Christopher P Salas-Wright; Michael G Vaughn; David R Hodge; Brian E Perron
Journal:  J Youth Adolesc       Date:  2012-04-03

2.  Alcohol Use Disorder and the Persistence/Recurrence of Major Depression: Le trouble de l'usage de l'alcool et la persistance/récurrence de la dépression majeure.

Authors:  Vivian N Onaemo; Timothy O Fawehinmi; Carl D'Arcy
Journal:  Can J Psychiatry       Date:  2020-05-04       Impact factor: 4.356

3.  A network approach to modeling comorbid internalizing and alcohol use disorders.

Authors:  Justin J Anker; Miriam K Forbes; Zack W Almquist; Jeremiah S Menk; Paul Thuras; Amanda S Unruh; Matt G Kushner
Journal:  J Abnorm Psychol       Date:  2017-02-09

Review 4.  Treatment of Adolescent Substance Use Disorders and Co-Occurring Internalizing Disorders: A Critical Review and Proposed Model.

Authors:  Leslie A Hulvershorn; Patrick D Quinn; Eric L Scott
Journal:  Curr Drug Abuse Rev       Date:  2015

Review 5.  Targeting the SAVA (Substance Abuse, Violence, and AIDS) Syndemic Among Women and Girls: A Global Review of Epidemiology and Integrated Interventions.

Authors:  Louisa Gilbert; Anita Raj; Denise Hien; Jamila Stockman; Assel Terlikbayeva; Gail Wyatt
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

Review 6.  At the crossroads: the intersection of substance use disorders, anxiety disorders, and posttraumatic stress disorder.

Authors:  Lesia M Ruglass; Teresa Lopez-Castro; Soumia Cheref; Santiago Papini; Denise A Hien
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

7.  Combining seeking safety with sertraline for PTSD and alcohol use disorders: A randomized controlled trial.

Authors:  Denise A Hien; Frances Rudnick Levin; Lesia M Ruglass; Teresa López-Castro; Santiago Papini; Mei-Chen Hu; Lisa Renee Cohen; Abigail Herron
Journal:  J Consult Clin Psychol       Date:  2015-01-26

8.  Alcohol-Adapted Anger Management Treatment: A Randomized Controlled Trial of an Innovative Therapy for Alcohol Dependence.

Authors:  Kimberly S Walitzer; Jerry L Deffenbacher; Kathleen Shyhalla
Journal:  J Subst Abuse Treat       Date:  2015-08-18

Review 9.  Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelines.

Authors:  U W Preuss; E Gouzoulis-Mayfrank; U Havemann-Reinecke; I Schäfer; M Beutel; E Hoch; K F Mann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-24       Impact factor: 5.270

10.  [Mental comorbidities of alcohol-related disorders].

Authors:  U W Preuss; E Gouzoulis-Mayfrank; U Havemann-Reinecke; I Schäfer; M Beutel; K F Mann; E Hoch
Journal:  Nervenarzt       Date:  2016-01       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.